Galvani Bioelectronics implants first neurostimulator for splenic nerve stimulation in rheumatoid arthritis patient

Galvani Bioelectronics, a joint venture between Verily and GSK, recently announced the first successful implantation of a neurostimulator that uses splenic nerve stimulation as an experimental therapy for rheumatoid arthritis patients.